2018 American Transplant Congress » Concurrent Session: B-cell / Antibody
Date: Monday, June 4, 2018
Time: 2:30pm-4:00pm
Location: Room 615/616/617
Session Type: Concurrent Session
Meeting: 2018 American Transplant Congress
- 2:30pm-2:42pm
CTLA4-Ig and Bortezomib Successfully Reverses Established DSA Responses in Allograft-Sensitized Recipients
- 2:42pm-2:54pm
Prevention and Reversal of Diabetes through Restoration of B and T Cell Regulation and Immune Homeostasis
« View all sessions from the 2018 American Transplant Congress